Our Science

We aim to redefine how fibrosis is treated. Our deep understanding of the molecular drivers of fibrotic disease allows us to target these drivers in the specific tissues where they are causing fibrosis. This approach has the potential to provide both a more potent antifibrotic effect, as well as better safety and tolerability than treatments available today.